Pfizer Licenses Out Compounds to Research Supply Company

Related tags Medicine License

Pfizer Licenses Out Compounds to Research Supply Company
The Big Pharma company has licensed a range of compounds to molecule research tools company Abcam to be made available for sale to pre-clinical researchers.

An Abcam spokesperson told “Pfizer are a leading research-based pharmaceutical company and we are proud to offer their products within our portfolio.

“This agreement gives our customers access to a diverse group of sought after research compounds”

The compounds – which include atorvastatin, doxorubicin, nifedipine and bosutinib – add to a number of products the company has acquired through licensing agreements, with Eli Lilly, the NIH and the University of Columbia on its books.

They will be used in a number of research fields including neuroscience, cardiovascular disease, cancer and antibiotic resistance.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more